Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease
about
sameAs
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseaseCarotid artery intima-media thickness and the renin-angiotensin systemImpact of medical therapy on atheroma volume measured by different cardiovascular imaging modalitiesRenin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusHydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE.Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialThe potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease.Angiotensin-converting enzyme inhibitors and stroke risk: benefit beyond blood pressure reduction?Primary and secondary prevention of stroke by antihypertensive drug treatment.Ramipril in the treatment of vascular diseases.Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with HypertensionThematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesDo men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.Effectiveness of blood pressure lowering: evidence-based comparisons between men and women.Imagine how many lives you save: angiotensin-converting enzyme inhibition for atherosclerotic vascular disease in the present era of risk reduction.Does achieving an intensive versus usual blood pressure level prevent stroke?Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.Use of predictive markers to improve cardiovascular protection.Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials.Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials.Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.Modern treatment of patients at risk: still a HOPE for ACE inhibitors?Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.2007 ESH‐ESC Guidelines for the management of arterial hypertensionBlood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis
P2860
Q24235834-9ED9E239-A5B6-4F0B-BE45-66EE7FE1E704Q26851516-AA598D93-2043-4618-9FC1-5D275E073AF5Q34018909-17CF1EED-E107-4F4B-9BDE-9C58D9008CB5Q34124779-9184CAC6-AD4E-4490-9677-3DE8F81D36EAQ34402692-CADC6785-B2F4-4D7B-BBFB-1550C24928D8Q34530229-38A922A7-5AEC-4D6A-8222-212E81AD982CQ35681739-AECDDADE-C60A-4809-9D3D-7CFDF58B1D82Q35763822-E327EBF5-EFBB-4F26-BB0C-BEBA57B55603Q35875450-5B3B84BC-4F5D-4189-822B-7C9D96E705B8Q36106927-BFB2E1B7-901F-4BFD-BE81-EE786F35B40FQ36249938-9A4F3D5B-69D0-4D84-A177-571F8C266136Q36426826-40BF1324-FD2A-4300-818E-019A8EFA2E5EQ36480698-AB8D0735-4E54-47CA-9FEE-0C6E605D8E7BQ37158159-E7329EF8-F7C9-45A8-88B1-04FB6EF86CD9Q37292868-36BC97B1-15B7-45EC-BA72-883CE1ADE518Q37688159-E849DEC2-EF4F-4EC3-ACE7-505C88D020C3Q37846720-ED90E4D0-2A49-49AB-A4CF-28852CC66A25Q37907176-E9FCE2B5-9B53-4C85-BDF5-10EEB125A61CQ40009748-F70AD7F2-C0D9-48F4-98CC-5FF62ABDDCCBQ40199205-730E2B8E-73FD-4DA8-BE86-E5E5B71898F8Q43886848-7DAAEBDD-7CA9-49F0-BAAF-B678CBF70AB4Q44295781-DC22D12B-7D3E-4D80-8B86-D757E8D0E4A4Q44313582-10C7A72E-AE0C-4B04-BAFB-BC3113286F9BQ44727959-0955CD2A-9DB2-4F40-814C-53BE5045E13BQ45269285-3C78CAD9-52EF-4737-A3B4-4976CF26A15FQ46956599-7859443E-16A7-423B-B571-65E28E18C0FEQ47817797-839D445A-4D81-4764-8B48-1D57EE74CE10Q50237679-227ABBDD-FD68-431F-8A15-C11B75FA1317Q56970799-8F3FE749-5E47-47F4-90B4-FCEB934BD6C0Q57085413-600B941C-06F8-4ECD-97EB-40F2B8B0FF8F
P2860
Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease
description
article
@en
im August 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2000
@uk
name
Randomized, placebo-controlled ...... her occlusive arterial disease
@en
Randomized, placebo-controlled ...... her occlusive arterial disease
@nl
type
label
Randomized, placebo-controlled ...... her occlusive arterial disease
@en
Randomized, placebo-controlled ...... her occlusive arterial disease
@nl
prefLabel
Randomized, placebo-controlled ...... her occlusive arterial disease
@en
Randomized, placebo-controlled ...... her occlusive arterial disease
@nl
P2093
P1476
Randomized, placebo-controlled ...... Atherosclerosis with Ramipril
@en
P2093
C N Mhurchu
S MacMahon
P304
P356
10.1016/S0735-1097(00)00736-1
P407
P577
2000-08-01T00:00:00Z